ResMed Inc. logo
RMDResMed Inc.

Dividends

Dividend payments are $2.40 per share, with a current dividend yield of 1.21%. The company has dividend history for 13 consecutive years.

RMD Dividend Summary

Consecutive Years

13

Most Recent Ex-Date

May 14, 2026

Most Recent Payment

Jun 18, 2026

RMD Dividends per Share (Nominal History)

View full nominal table list

This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.

RMD Dividends CAGR Chart

ResMed Inc. (RMD)

Annual Dividend History

YearDividend/ShareYoY Growth
2026(YTD)$1.20
2025$2.26+11.88%
2024$2.02+9.78%
2023$1.84+6.98%
2022$1.72+6.17%
2021$1.62+3.85%
2020$1.56+2.63%
2019$1.52+5.56%
2018$1.44+5.88%
2017$1.36+7.94%
2016$1.26+8.62%
2015$1.16+9.43%
2014$1.06+26.19%
2013$0.84N/A
2012$0.34N/A

Quarterly Dividend History

QuarterDividend/ShareYoY Growth
Q2 2026$0.60+13.21%
Q1 2026$0.60+13.21%
Q4 2025$0.60+13.21%
Q3 2025$0.60+13.21%
Q2 2025$0.53+10.42%
Q1 2025$0.53+10.42%
Q4 2024$0.53+10.42%
Q3 2024$0.53+10.42%
Q2 2024$0.48+9.09%
Q1 2024$0.48+9.09%
Q4 2023$0.48+9.09%
Q3 2023$0.48+9.09%
Q2 2023$0.44+4.76%
Q1 2023$0.44+4.76%
Q4 2022$0.44+4.76%
Q3 2022$0.44+4.76%
Q2 2022$0.42+7.69%
Q1 2022$0.42+7.69%
Q4 2021$0.42+7.69%
Q3 2021$0.42+7.69%
Q2 2021$0.39+0.00%
Q1 2021$0.39+0.00%
Q4 2020$0.39+0.00%
Q3 2020$0.39+0.00%

Dividend Yield Metrics

Current Yield
1.21%
Average Yield (TTM)
1.21%
Average Yield (3Y)
1.03%
Forward Yield on Cost (3Y)
1.69%
Forward Yield on Cost (5Y)
2.10%
Forward Yield on Cost (10Y)
3.67%

Payout Ratio Analysis

Payout Ratio (Current)
23.21%
FCF Payout Ratio
20.14%
Payout Ratio (3Y Avg)
27.61%
Payout Ratio (5Y Avg)
32.92%
FCF Payout (3Y Avg)
30.44%
FCF Payout (5Y Avg)
51.61%

Dividend Coverage

Payout Ratio
23.2%
Dividends / net income
FCF Payout Ratio
20.1%
Dividends / free cash flow
Consecutive Years
13 years
Years with regular dividend payments
5Y Dividend Growth
7.7%
Compound annual dividend growth

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

San Diego, CA
9,980 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael J. Farrell